ENHERTU
Powder for concentrate for solution for infusion, 100mg
RxActive license
Active substance (INN)
trastuzumab deruxtecan
Pharmaceutical form
Pharmaceutical formPowder for concentrate for solution for infusion
Strength100mg
PackagingUkupno 1 bočica staklena sa praškom za koncentrat za rastvor za infuziju u kartonskoj kutiji
ManufacturerDaiichi Sankyo Europe GmbH, Germany
Therapeutic groupAntineoplastic and immunomodulating agents (L01FD04)
Marketing authorization holderDRUŠTVO ZA TRGOVINU NA VELIKO FARMACEUTSKIM PROIZVODIMA "GLOSARIJ" D.O.O.-PODGORICA
Authorization dateFebruary 5, 2024
Source: CInMED register